Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer patents cyclin-dependent kinase inhibitors

Nov. 15, 2019

New mu-opioid receptor agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

Nov. 15, 2019

ViiV Healthcare synthesizes prodrugs of HIV maturation inhibitors

Nov. 15, 2019

Janssen describes compounds for respiratory syncytial virus infections

Nov. 15, 2019

Preclinical data suggest MCLA-129 has potential for NSCLC resistant to EGFR-targeted therapies

Nov. 15, 2019

Preliminary phase I/II data for BMS-986148 monotherapy and combination with nivolumab

Nov. 15, 2019

Gilead presents phase II results for selgantolimod in patients with chronic HBV

Nov. 15, 2019

Hoth Therapeutics initiates preclinical testing of topical aprepitant

Nov. 15, 2019

First patient dosed in phase Ib/IIa proof-of-concept study of BRII-179

Nov. 15, 2019

Cerveau Technologies starts Japanese phase I study of [18F]MK-6240

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...